ReleaseWire

Reportstack, provider of premium market research reports announces the addition of IMMD Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Clera Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of ProteoTech, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Zosano, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Molecular Design International, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Genextra S.p.a. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of FAES Farma SA - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Celsus Therapeutics Plc - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Lipella Pharmaceuticals, Inc. - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Muscle Atrophy - Pipeline Review, H2 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Hypogonadotropic Hypogonadism - Pipeline Review, H2 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Uterine Cancer - Pipeline Review, H2 2014 market report to its offering

Reportstack, provider of premium market research reports announces the addition of Burkitt Lymphoma - Pipeline Review, H2 2014 market report to its offering

Chemical reagent, purified from industrial chemicals, serves chiefly scientific experiment and detection analysis, and finds massive application in electronic information, medicine, food, aerospace and military industry manufacturing.

Since the age of 12, Donna Jackson has been singing in churches throughout the United States and Canada. As a young girl, her grandmother would encourage Donna to sing for her local congregation. Before long, it became obvious that Donna possesses a divine gift -- a heavenly voice and the ability to inspire others through music. One cannot help but feel at peace as they listen to the purity of Donna’s voice and the messages contained in her songs.

LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Frankfurt: DH8B, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7) (the “Company”) announced August 15, 2014 that it has received approval from the TSX Venture Exchange to the acquisition of 1,200,000 common shares at $0.25 per share of MatNic Resources Inc. The transaction was subject to Mat|Nic Resources Inc. receiving regulatory approval to a reverse takeover (“RTO”) by Graphene 3D Labs Inc. (“Graphene 3D”) (TSXV: GGG) (formerly named MatNic Resources Inc.).

Synopsis

Synopsis